Chairman's Corner

Welcome to the spring edition of the Caris Connection enewsletter.

POA Site Highlight

In October 2020, the Huntsman Cancer Institute at the University of Utah officially became the 44th member of the Caris Precision Oncology Alliance™ (POA). 

Know Your Investigator

We recently caught up with Dr. Charu Aggarwal, Associate Professor for Lung Cancer Excellence in the Division of Hematology-Oncology at the University of Pennsylvania’s Perelman School of Medicine. 

Caris Molecular Minute Podcast

Tune in to hear POA Chairman Chadi Nabhan interview many of today’s leading experts as they discuss the latest developments in the fields of oncology and precision medicine.

Feature Stories

Chairman’s Corner

View the latest Chairman’s Corner message for our spring edition of Caris Connection. In this issue, you will discover Caris’ latest treatment prediction AI technologies as well as profound insights...

read more

POA Institution Spotlight

ABOUT Huntsman Cancer Institute (HCI) at the University of Utah is the official cancer center of Utah. The cancer campus includes a state-of-the-art cancer specialty hospital as well as two...

read more

Know Your Investigator

Dr. Chadi Nabhan recently caught up with Dr. Charu Aggarwal, Leslye M. Heisler Associate Professor for Lung Cancer Excellence in the Division of Hematology-Oncology at the University of...

read more

Molecular Minute Podcasts

Tune in to hear POA Chairman Chadi Nabhan interview many of today’s leading oncology experts as they discuss the latest developments and breakthroughs in the fields of oncology and precision medicine.

read more

Caris Scientific Advances

Caris Life Sciences® continues to be at the forefront of innovation in molecular science and artificial intelligence (AI) with the recent publications of MI FOLFOXai™ and MI GPSai™. These AI-based, molecular signature prediction tools have advanced personalized medicine by providing more diagnostic insight and overall more effective individualized treatments. These platforms are discussed in more detail here.

Caris Lab Update

As Caris continues to expand its capabilities with the recent launch of new products like MI GPSai™, MI FOLFOXai™ and Whole Exome Sequencing, efforts have been made to expand the laboratory services necessary to support products like these and the platforms behind them. Read more about how Caris is continuing to expand these capabilities, giving even more patients with cancer access to personalized medicine.

Around the POA

Throughout the year, members of the POA make headlines with promotions, grants, breakthroughs, and awards. Catch up on the latest happenings within the POA here.

Upcoming Meetings & Events

Contact Caris Precision Oncology Alliance

If you require additional information on the POA, have questions, comments, or ideas, we’d love to hear from you. Please click on the link below.